capeox
Showing 1 - 11 of 11
Colon Cancer, Neoadjuvant Therapy, Immunotherapy Trial in Guangzhou (Envafolimab, CAPEOX)
Recruiting
- Colon Cancer
- +2 more
- Envafolimab
- CAPEOX
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 26, 2023
Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)
Not yet recruiting
- Rectal Cancer
- Locally Advanced
- Short-course radiotherapy
- +3 more
- (no location specified)
Oct 8, 2022
Rectal Cancer Trial in Shanghai (FOLFOXIRI, CapeOX)
Recruiting
- Rectal Cancer
- FOLFOXIRI
- CapeOX
-
Shanghai, Shanghai, ChinaDepartment of Colorectal Surgery Fudan University Shanghai Caner
Feb 16, 2022
Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)
Not yet recruiting
- Colon Cancer
- Immunotherapy
- Terelizumab
- CapeOx
-
Chongqing, ChinaDaping hospital
Apr 16, 2023
Neoadjuvant Treatment, Rectal Cancer, Anlotinib Trial (Anlotinib+Capeox, Capeox)
Withdrawn
- Neoadjuvant Treatment
- +2 more
- Anlotinib+Capeox
- Capeox
- (no location specified)
Sep 22, 2021
Unresectable Metastatic Colorectal Cancer Trial in China (AK105 injection, Anlotinib HCl capsule, CapeOX)
Recruiting
- Unresectable Metastatic Colorectal Cancer
- AK105 injection
- +3 more
-
Lanzhou, Gansu, China
- +12 more
Oct 18, 2021
Colonic Tumors Trial (Dostarlimab, CAPEOX, FOLFOX)
Not yet recruiting
- Colonic Neoplasms
- Dostarlimab
- +2 more
- (no location specified)
May 3, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- Regorafenib
- +3 more
-
Kashiwa, Chiba, JapanNational Cancer Center Hospital East
May 23, 2022
Tumors, Colorectal Trial in India, United Kingdom (Pazopanib, FOLFOX 6, CapeOx)
Completed
- Neoplasms, Colorectal
- Pazopanib
- +2 more
-
Hyderabad, Andhra Pradesh, India
- +4 more
Nov 13, 2017